Last reviewed · How we verify
NCT07129876
Motion Fidelity Effects With Mixed-Reality
NA trial testing Simulator Motion in Healthy in 13 participants. Completed in 30 May 2025.
30 May 2025
Quick facts
| Lead sponsor | National Aeronautics and Space Administration (NASA) |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 13 |
| Start date | 19 May 2025 |
| Primary completion | 30 May 2025 |
| Estimated completion | 30 May 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Simulator Motion
Conditions studied
- Healthy — all drugs for Healthy →
Sponsor
National Aeronautics and Space Administration (NASA) — full company profile →
Who can join
18 and older, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this research is to investigate how different levels of simulator motion fidelity affect pilot performance in two different flight tasks while using a head mounted display (or mixed-reality headset) for out-the-window (OTW) visuals. Three levels of motion fidelity will be studied: 1) no motion, 2) small hexapod motion, and 3) one-to-one vehicle motion.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07129876
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other National Aeronautics and Space Administration (NASA) trials
Trials by the same sponsor.
- NCT06531733 — Artemis Sleep Countermeasures · NA · recruiting
- NCT06476106 — Human Research Program Flight Thigh Cuff · NA · enrolling by invitation
- NCT05366933 — B-Complex: A Nutraceutical SANS Countermeasure · Phase 1 · recruiting
- NCT06500338 — Determining the Dose Response Profile of the Headward Fluid Shift During Varying Gravity Levels · NA · completed
- NCT03526575 — Optimize Astronaut Sleep Medication Efficacy and Individual Effects · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07129876 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Aeronautics and Space Administration (NASA)
- Last refreshed: 13 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07129876.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing